ECOG E5202: “A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin versus 5FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers”
FER-HO-001: “Measuring Quality Improvement
in Breast Cancer Care and Management”
GOG 0219: “A Phase III, Randomized Trial
of Weekly Cisplatin and Radiation vs. Cisplatin and Tirapazamine
and Radiation in Stage IB2, IIB, IIIB, IVA Cervical Carcinoma
Limited to the Pelvis” (NCI
Version 11/20/06)
IRB 07-013: (Non-Oncology): ASCEND-HF: A
Double-Blind, Placebo-Controlled, Multicenter Acute Study of Clinical
Effectiveness of Nesiritide in Subjects with Decompensated Heart
Failure
IRB 07-014: “Phase III Randomized Study of Calendula vs. Biafine to Prevent Radiation-Induced Dermatitis”
IRB 08-009: (Non-Oncology) Randomized Study of Non-Emergent
Percutaneous Coronary Intervention in Hospitals With and Without
On-site Cardiac Surgery (Atlantic C-PORT E)
IRB 08-011: Familial colorectal Cancer Registry Program at Monmouth Medical Center
IRB 09-004: (Non-Oncology) A Multinational-Multicenter,
Double-Blind, Randomized, Parallel Group Study to Compare the Safety
and Efficacy of 200 mg PAR-101 Taken q12H with 125 mg Vancomycin
Taken q6H for Ten Days in Subjects with Clostridium Difficile-Associated
Diarrhea
PACCT-1/TAILORx: “Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning Individualized Options for Treatment”
RTOG 0413/B39 “A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I or II Breast Cancer”
RTOG 0436: “a Phase III Teial Evaluating
the Addition of Cetuximab to Paclitaxel, Cisplatin and Radiation
for Patients with Esophageal Cancer Who Are Treated Without Surgery”
RTOG 0614: A Randomized, Phase III, Double-Blind, Placebo-Controlled
Trial of Memantine for Prevention of Cognitive Dysfunction in
Patients Receiving Whole Brain Radiotherapy
RTOG 0617: “A Randomized Phase III Comparison
of Standard-Dose (60Gy) versus High-Dose (74Gy) Conformal Radiotherapy
with Concurrent and Consolidation Carboplatin/Paclitaxel in Patients
with Stage IIIA/IIIB Non-Small Cell Lung Cancer”
RTOG 0619: A Randomized Phase II Trial of Chemoradiotherapy versus
Chemoradiotherapy and Vandetanib for High-Risk Postoperative Advanced
Squamous Cell Carcinoma of the Head and Neck
RTOG 0822: A Phase II Evaluation of Preoperative Chemoradiotherapy
Utilizing Intensity Modulated Radiation Therapy (IMRT) in Combination
with Capecitabine and Oxaliplatin for Patients with Locally Advanced
Rectal Cancer
[ medical services index ] [ top ] |
